FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

717359004: Selexipag (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3309174011 Selexipag (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3309175012 Selexipag en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selexipag Is a Vasodilator true Inferred relationship Existential restriction modifier
Selexipag Is a Acetamide true Inferred relationship Existential restriction modifier
Selexipag Is a Pyrazine true Inferred relationship Existential restriction modifier
Selexipag Has disposition Prostacyclin receptor agonist true Inferred relationship Existential restriction modifier
Selexipag Is a Substance with platelet aggregation inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Selexipag Has disposition Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier
Selexipag Is a Substance with prostacyclin receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing selexipag (medicinal product) Has active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Selexipag Has active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing selexipag in oral dose form (medicinal product form) Has active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing only selexipag in oral dose form (medicinal product form) Has active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 200 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 200 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 400 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 400 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 600 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 600 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.4 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.4 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 800 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 800 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.2 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.2 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.6 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Selexipag Inferred relationship Existential restriction modifier 1
Product containing precisely selexipag 1.6 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Selexipag Inferred relationship Existential restriction modifier 1
Selexipag 200microgram tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 600microgram tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 800microgram tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1mg tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.2mg tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.4mg tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 400microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 600microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 800microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,200microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,400microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,600microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.6mg tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.4mg tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1.2mg tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 1mg tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 800microgram tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 600microgram tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 400microgram tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 140 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 10 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 140 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 400microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 600microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 800microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,000microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,200microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,400microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier
Uptravi 1,600microgram tablets (Janssen-Cilag Ltd) 60 tablet Has specific active ingredient True Selexipag Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start